(7S)-5-[[7-[5-[(1R)-2-(2,2-difluoroethyl)-3-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl]pyrimidin-2-yl]-7-azaspiro[3.5]nonan-2-yl]methyl]-9-methyl-13-(6-methylidene-2-oxopiperidin-3-yl)-2,5,9,13-tetrazatetracyclo[8.7.0.02,7.011,15]heptadeca-1(10),11(15),16-trien-14-one

C47H56F2N10O2 — CID 170727978

IUPAC(7S)-5-[[7-[5-[(1R)-2-(2,2-difluoroethyl)-3-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl]pyrimidin-2-yl]-7-azaspiro[3.5]nonan-2-yl]methyl]-9-methyl-13-(6-methylidene-2-oxopiperidin-3-yl)-2,5,9,13-tetrazatetracyclo[8.7.0.02,7.011,15]heptadeca-1(10),11(15),16-trien-14-one
SMILESC=C1CCC(N2Cc3c(ccc4c3N(C)C[C@@H]3CN(CC5CC6(CCN(c7ncc([C@@H]8c9[nH]c%10ccccc%10c9CC(C)N8CC(F)F)cn7)CC6)C5)CCN43)C2=O)C(=O)N1
InChIInChI=1S/C47H56F2N10O2/c1-28-8-10-39(44(60)52-28)59-26-36-34(45(59)61)9-11-38-43(36)54(3)24-32-25-55(16-17-57(32)38)23-30-19-47(20-30)12-14-56(15-13-47)46-50-21-31(22-51-46)42-41-35(18-29(2)58(42)27-40(48)49)33-6-4-5-7-37(33)53-41/h4-7,9,11,21-22,29-30,32,39-40,42,53H,1,8,10,12-20,23-27H2,2-3H3,(H,52,60)/t29?,32-,39?,42-/m1/s1
InChIKeyGJDIWELUGHKUJR-LJKFZKFQSA-N
MW831.03 g/mol
LogP5.94
Rot. Bonds7

About (7S)-5-[[7-[5-[(1R)-2-(2,2-difluoroethyl)-3-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl]pyrimidin-2-yl]-7-azaspiro[3.5]nonan-2-yl]methyl]-9-methyl-13-(6-methylidene-2-oxopiperidin-3-yl)-2,5,9,13-tetrazatetracyclo[8.7.0.02,7.011,15]heptadeca-1(10),11(15),16-trien-14-one

(7S)-5-[[7-[5-[(1R)-2-(2,2-difluoroethyl)-3-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl]pyrimidin-2-yl]-7-azaspiro[3.5]nonan-2-yl]methyl]-9-methyl-13-(6-methylidene-2-oxopiperidin-3-yl)-2,5,9,13-tetrazatetracyclo[8.7.0.02,7.011,15]heptadeca-1(10),11(15),16-trien-14-one (PubChem CID 170727978) has the molecular formula C47H56F2N10O2 and a molecular weight of 831.03 g/mol. Its IUPAC name is (7S)-5-[[7-[5-[(1R)-2-(2,2-difluoroethyl)-3-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl]pyrimidin-2-yl]-7-azaspiro[3.5]nonan-2-yl]methyl]-9-methyl-13-(6-methylidene-2-oxopiperidin-3-yl)-2,5,9,13-tetrazatetracyclo[8.7.0.02,7.011,15]heptadeca-1(10),11(15),16-trien-14-one.

Molecular Properties

Compound Name(7S)-5-[[7-[5-[(1R)-2-(2,2-difluoroethyl)-3-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl]pyrimidin-2-yl]-7-azaspiro[3.5]nonan-2-yl]methyl]-9-methyl-13-(6-methylidene-2-oxopiperidin-3-yl)-2,5,9,13-tetrazatetracyclo[8.7.0.02,7.011,15]heptadeca-1(10),11(15),16-trien-14-one
PubChem CID170727978
Molecular FormulaC47H56F2N10O2
Molecular Weight831.03 g/mol
Exact Mass830.46
IUPAC Name(7S)-5-[[7-[5-[(1R)-2-(2,2-difluoroethyl)-3-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl]pyrimidin-2-yl]-7-azaspiro[3.5]nonan-2-yl]methyl]-9-methyl-13-(6-methylidene-2-oxopiperidin-3-yl)-2,5,9,13-tetrazatetracyclo[8.7.0.02,7.011,15]heptadeca-1(10),11(15),16-trien-14-one
SMILESC=C1CCC(N2Cc3c(ccc4c3N(C)C[C@@H]3CN(CC5CC6(CCN(c7ncc([C@@H]8c9[nH]c%10ccccc%10c9CC(C)N8CC(F)F)cn7)CC6)C5)CCN43)C2=O)C(=O)N1
InChIInChI=1S/C47H56F2N10O2/c1-28-8-10-39(44(60)52-28)59-26-36-34(45(59)61)9-11-38-43(36)54(3)24-32-25-55(16-17-57(32)38)23-30-19-47(20-30)12-14-56(15-13-47)46-50-21-31(22-51-46)42-41-35(18-29(2)58(42)27-40(48)49)33-6-4-5-7-37(33)53-41/h4-7,9,11,21-22,29-30,32,39-40,42,53H,1,8,10,12-20,23-27H2,2-3H3,(H,52,60)/t29?,32-,39?,42-/m1/s1
InChIKeyGJDIWELUGHKUJR-LJKFZKFQSA-N
XLogP5.94
TPSA107.18 Ų
H-Bond Donors2
H-Bond Acceptors9
Rotatable Bonds7
Heavy Atoms61
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500831.03
LogP ≤ 55.94
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'indol_3yl_alk(461)', 'substructure': 'N/A'}

Analyze (7S)-5-[[7-[5-[(1R)-2-(2,2-difluoroethyl)-3-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl]pyrimidin-2-yl]-7-azaspiro[3.5]nonan-2-yl]methyl]-9-methyl-13-(6-methylidene-2-oxopiperidin-3-yl)-2,5,9,13-tetrazatetracyclo[8.7.0.02,7.011,15]heptadeca-1(10),11(15),16-trien-14-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (7S)-5-[[7-[5-[(1R)-2-(2,2-difluoroethyl)-3-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl]pyrimidin-2-yl]-7-azaspiro[3.5]nonan-2-yl]methyl]-9-methyl-13-(6-methylidene-2-oxopiperidin-3-yl)-2,5,9,13-tetrazatetracyclo[8.7.0.02,7.011,15]heptadeca-1(10),11(15),16-trien-14-one?
The IUPAC name of (7S)-5-[[7-[5-[(1R)-2-(2,2-difluoroethyl)-3-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl]pyrimidin-2-yl]-7-azaspiro[3.5]nonan-2-yl]methyl]-9-methyl-13-(6-methylidene-2-oxopiperidin-3-yl)-2,5,9,13-tetrazatetracyclo[8.7.0.02,7.011,15]heptadeca-1(10),11(15),16-trien-14-one (CID 170727978) is (7S)-5-[[7-[5-[(1R)-2-(2,2-difluoroethyl)-3-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl]pyrimidin-2-yl]-7-azaspiro[3.5]nonan-2-yl]methyl]-9-methyl-13-(6-methylidene-2-oxopiperidin-3-yl)-2,5,9,13-tetrazatetracyclo[8.7.0.02,7.011,15]heptadeca-1(10),11(15),16-trien-14-one.
What is the SMILES notation for (7S)-5-[[7-[5-[(1R)-2-(2,2-difluoroethyl)-3-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl]pyrimidin-2-yl]-7-azaspiro[3.5]nonan-2-yl]methyl]-9-methyl-13-(6-methylidene-2-oxopiperidin-3-yl)-2,5,9,13-tetrazatetracyclo[8.7.0.02,7.011,15]heptadeca-1(10),11(15),16-trien-14-one?
The canonical SMILES for (7S)-5-[[7-[5-[(1R)-2-(2,2-difluoroethyl)-3-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl]pyrimidin-2-yl]-7-azaspiro[3.5]nonan-2-yl]methyl]-9-methyl-13-(6-methylidene-2-oxopiperidin-3-yl)-2,5,9,13-tetrazatetracyclo[8.7.0.02,7.011,15]heptadeca-1(10),11(15),16-trien-14-one is C=C1CCC(N2Cc3c(ccc4c3N(C)C[C@@H]3CN(CC5CC6(CCN(c7ncc([C@@H]8c9[nH]c%10ccccc%10c9CC(C)N8CC(F)F)cn7)CC6)C5)CCN43)C2=O)C(=O)N1.
What is the InChIKey of (7S)-5-[[7-[5-[(1R)-2-(2,2-difluoroethyl)-3-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl]pyrimidin-2-yl]-7-azaspiro[3.5]nonan-2-yl]methyl]-9-methyl-13-(6-methylidene-2-oxopiperidin-3-yl)-2,5,9,13-tetrazatetracyclo[8.7.0.02,7.011,15]heptadeca-1(10),11(15),16-trien-14-one?
The InChIKey is GJDIWELUGHKUJR-LJKFZKFQSA-N. The full InChI is InChI=1S/C47H56F2N10O2/c1-28-8-10-39(44(60)52-28)59-26-36-34(45(59)61)9-11-38-43(36)54(3)24-32-25-55(16-17-57(32)38)23-30-19-47(20-30)12-14-56(15-13-47)46-50-21-31(22-51-46)42-41-35(18-29(2)58(42)27-40(48)49)33-6-4-5-7-37(33)53-41/h4-7,9,11,21-22,29-30,32,39-40,42,53H,1,8,10,12-20,23-27H2,2-3H3,(H,52,60)/t29?,32-,39?,42-/m1/s1.
What are the key properties of (7S)-5-[[7-[5-[(1R)-2-(2,2-difluoroethyl)-3-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl]pyrimidin-2-yl]-7-azaspiro[3.5]nonan-2-yl]methyl]-9-methyl-13-(6-methylidene-2-oxopiperidin-3-yl)-2,5,9,13-tetrazatetracyclo[8.7.0.02,7.011,15]heptadeca-1(10),11(15),16-trien-14-one?
(7S)-5-[[7-[5-[(1R)-2-(2,2-difluoroethyl)-3-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl]pyrimidin-2-yl]-7-azaspiro[3.5]nonan-2-yl]methyl]-9-methyl-13-(6-methylidene-2-oxopiperidin-3-yl)-2,5,9,13-tetrazatetracyclo[8.7.0.02,7.011,15]heptadeca-1(10),11(15),16-trien-14-one has a molecular weight of 831.03 g/mol, XLogP of 5.94, 7 rotatable bonds, 2 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for (7S)-5-[[7-[5-[(1R)-2-(2,2-difluoroethyl)-3-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl]pyrimidin-2-yl]-7-azaspiro[3.5]nonan-2-yl]methyl]-9-methyl-13-(6-methylidene-2-oxopiperidin-3-yl)-2,5,9,13-tetrazatetracyclo[8.7.0.02,7.011,15]heptadeca-1(10),11(15),16-trien-14-one is sourced from PubChem (CID 170727978), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).